The central drug regulator released two lists – one was a list of 48 drugs that failed the quality tests and another had ...

According to DelveInsight’s analysis, the growth of the KRAS Inhibitors market is expected to be mainly driven by increasing incidence, a rise in awareness and access to treatment, and robust pipeline ...

The Central Drugs Standard Control Organisation (CDSCO) has flagged over 50 drugs, including Paracetamol, as 'not of standard ...

Merck and Daiichi Sankyo have passed a Phase 3 with the lead antibody-drug conjugate from the megadeal they disclosed at last ...

In its latest drug alert, the apex drug regulatory body, the Central Drug Standard Control Organization (CDSCO), has flagged ...

One of the major dangers of taking substandard medications is the risk of prolonged health issues. PCM (paracetamol), for ...

Trinity plans to bring to market in 2025 Metabolomics Diagnostics' PrePsia test that can be used to determine preeclampsia risk in the 12th week of pregnancy.

The CDSCO’s August 2024 report categorized several medications under its “Not of Standard Quality (NSQ Alert)” list, which ...

ASX falls on Wednesday with banks dragging down market. Lithium stocks surge on CATL suspension reports; MinRes jumps 16.2pc.